Show simple item record

dc.contributor.authorFernández-Friera, Leticia
dc.contributor.authorGarcía-Alvarez, Ana
dc.contributor.authorOliva, Belen 
dc.contributor.authorGarcía-Lunar, Inés
dc.contributor.authorGarcía, Iris
dc.contributor.authorMoreno-Arciniegas, Andrea
dc.contributor.authorGómez-Talavera, Sandra
dc.contributor.authorPérez-Herreras, Cristina
dc.contributor.authorSánchez-González, Javier
dc.contributor.authorde Vega, Vicente Martinez
dc.contributor.authorRossello, Xavier 
dc.contributor.authorBueno, Héctor
dc.contributor.authorFernández-Ortiz, Antonio
dc.contributor.authorIbañez, Borja
dc.contributor.authorSanz, Javier 
dc.contributor.authorFuster, Valentín
dc.date.accessioned2024-07-09T10:50:37Z
dc.date.available2024-07-09T10:50:37Z
dc.date.issued2024-06-28
dc.identifier.citationEur Heart J Cardiovasc Imaging. 2024 Jun 28;25(7):968-975.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/20323
dc.description.abstractAIMS Evidence on the association between subclinical atherosclerosis (SA) and cardiovascular (CV) events in low-risk populations is scant. To study the association between SA burden and an ischaemic scar (IS), identified by cardiac magnetic resonance (CMR), as a surrogate of CV endpoint, in a low-risk population. METHODS AND RESULTS A cohort of 712 asymptomatic middle-aged individuals from the Progression of Early SA (PESA-CNIC-Santander) study (median age 51 years, 84% male, median SCORE2 3.37) were evaluated on enrolment and at 3-year follow-up with 2D/3D vascular ultrasound (VUS) and coronary artery calcification scoring (CACS). A cardiac magnetic study (CMR) was subsequently performed and IS defined as the presence of subendocardial or transmural late gadolinium enhancement (LGE). On CMR, 132 (19.1%) participants had positive LGE, and IS was identified in 20 (2.9%) participants. Individuals with IS had significantly higher SCORE2 at baseline and higher CACS and peripheral SA burden (number of plaques by 2DVUS and plaque volume by 3DVUS) at both SA evaluations. High CACS and peripheral SA (number of plaques) burden were independently associated with the presence of IS, after adjusting for SCORE2 [OR for 3rd tertile, 8.31; 95% confidence interval (CI) 2.85-24.2; P < 0.001; and 2.77; 95% CI, 1.02-7.51; P = 0.045, respectively] and provided significant incremental diagnostic value over SCORE2. CONCLUSION In a low-risk middle-aged population, SA burden (CAC and peripheral plaques) was independently associated with a higher prevalence of IS identified by CMR. These findings reinforce the value of SA evaluation to early implement preventive measures. CLINICAL TRIAL REGISTRATION Progression of Early Subclinical Atherosclerosis (PESA) Study Identifier: NCT01410318.es_ES
dc.description.sponsorshipThe PESA study is co-funded equally by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain, and Banco Santander, Madrid, Spain. The study also receives funding from the Instituto de Salud Carlos III (ISCIII, PI15/02019) and the European Regional Development Fund (ERDF) ‘Una manera de hacer Europa’. The CNIC is supported by the ISCIII, the Ministerio de Ciencia e Innovación and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (CEX2020-001041-S).es_ES
dc.language.isoenges_ES
dc.publisherOxford University Press es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshMyocardial Infarction es_ES
dc.subject.meshMagnetic Resonance Imaging, Cine es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshFemale es_ES
dc.subject.meshRisk Assessment es_ES
dc.subject.meshCohort Studies es_ES
dc.subject.meshAtherosclerosis es_ES
dc.subject.meshCoronary Artery Disease es_ES
dc.subject.meshAsymptomatic Diseases es_ES
dc.subject.meshProspective Studies es_ES
dc.subject.meshAdult es_ES
dc.titleAssociation between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID38426763es_ES
dc.format.volume25es_ES
dc.format.number7es_ES
dc.format.page968es_ES
dc.identifier.doi10.1093/ehjci/jeae044es_ES
dc.contributor.funderCentro Nacional de Investigaciones Cardiovasculares Carlos III (España) es_ES
dc.contributor.funderBanco Santander es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.contributor.funderFundación ProCNIC es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2047-2412es_ES
dc.relation.publisherversion10.1093/ehjci/jeae044es_ES
dc.identifier.journalEuropean heart journal. Cardiovascular Imaginges_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Imagen Cardiovascular y Estudios Poblacionaleses_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI15/02019es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CEX2020-001041-Ses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional